High DNAJC10 expression indicates poor prognosis of glioma patients
(A–C) Kaplan–Meier survival curves indicated that glioma patients with higher DNAJC10 expression level showed shorter survival time and rate in three independent glioma cohorts (TCGA, CGGAseq1 and CGGAseq2). (D–F) ROC curves showed that DNAJC10 was a robust and stable prognostic indicator in glioma patients. (G,H) The prognostic role of DNAJC10 remained strong in LGGs (G) and GBM (H).